Concepedia
3
Publications
89
Citations
H-Index
2023
Active since
Affiliations
Mersana Therapeutics (United States)(Current)
Jahna Soomer-James is an author at Mersana Therapeutics (United States).
Publications per year
2023–2025
Tumor cell-directed STING agonist antibody-drug conjugates induce type III interferons and anti-tumor innate immune responses
Naniye Malli Cetinbas, Travis Monnell, Jahna Soomer-James et al. · Nature Communications · 2024 · 55 citations · Full text
XMT-2056, a HER2-Directed STING Agonist Antibody–Drug Conjugate, Induces Innate Antitumor Immune Responses by Acting on Cancer Cells and Tumor-Resident Immune Cells
Raghida A. Bukhalid, Jeremy R. Duvall, Kelly L. Lancaster et al. · Clinical Cancer Research · 2025 · 20 citations · Full text
Abstract 4423: XMT-2056, a HER2-targeted STING agonist antibody-drug conjugate, exhibits ADCC function that synergizes with STING pathway activation and contributes to anti-tumor responses
Jahna Soomer-James, Marc Damelin, Naniye Malli · Cancer Research · 2023 · 14 citations
Rows per page
1–3 of 3